Memphis Pharmaceuticals & Chemical Industries Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Bassem Abdullah
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.8yrs |
| CEO ownership | n/a |
| Management average tenure | 4.9yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
CEO
Bassem Abdullah
Dr. Bassem Muhammad Abdullah is CEO, Executive MD & Director of Memphis Pharmaceuticals & Chemical Industries from August 2021.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Executive MD & Director | 3.8yrs | no data | no data | |
| Head of the Financial Sector | 5.4yrs | no data | no data | |
| Head of Administrative Affairs & HR | 4.9yrs | no data | no data | |
| Head of Legal Affairs Sector | no data | no data | no data | |
| Head of Production Sector | no data | no data | no data | |
| Head of the Engineering Sector | no data | no data | no data | |
| Head of Warehouse & Procurement Sector | no data | no data | no data | |
| Head of Quality Assurance & Internal Auditing Sector | 4.9yrs | no data | no data | |
| Head of Planning & Information Systems Sector | 4.9yrs | no data | no data | |
| Head of Research & Supervision Sector | 5.4yrs | no data | no data |
Experienced Management: MPCI's management team is considered experienced (4.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Executive MD & Director | 3.8yrs | no data | no data | |
| Non-Executive Chairman | 4yrs | no data | no data | |
| Director | no data | no data | no data | |
| Independent Director | no data | no data | no data | |
| Director | 3.4yrs | no data | no data | |
| Director | no data | no data | no data |
Experienced Board: MPCI's board of directors are considered experienced (3.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/14 20:07 |
| End of Day Share Price | 2025/06/12 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Memphis Pharmaceuticals & Chemical Industries is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.